Overview of the Second Annual Life Sciences Mission to Israel — June 26-30, 2005
Two Tracks, One Mission, One Unbelievable and Unmatched Experience in Israel
Join world wide luminaries as we travel to the land of innovation - ISRAEL!
One hundred of the world’s thought leaders in venture capital, market analysis, investment banking, government and regulatory agencies, business, academia, and research as well as leading CEO’s, CIO’s, and CTO’s will join for this "by invitation only" Mission to Israel.
The Mission will be officially hosted by The New Jerusalem Foundation; The Jerusalem Development Authority; Mr. Ehud Olmert - Vice Prime Minister and Minister of Industry, Labor and Trade; Mr. Danny Naveh - Minister of Health; and Mr. Uri Lupoliansky - Mayor of Jerusalem.
|Meetings with Israel’s political leaders, including the Prime Minister, Minister of Health, Minister of Science, Chief Scientist, former Prime Minister Binyamin Netanyahu, and Nobel Laureate and former Prime Minister Shimon Peres.|
|Personal interaction, keynote panels, and sector outlook roundtables between attendees, leading venture capitalists, and Life Science start-ups.|
|Collaborative exploration of joint ventures, investments and acquisitions for prescreened opportunities, and presentations by 100 of Israel’s most exciting venture-backed startups.|
|A one-day conference with 500 of Israel’s leaders in Life Sciences co-sponsored by the Harvard MIT Biomedical Engineering Center.|
|Exclusive touring of Israel featuring helicopter trips to Masada and the Golan Heights, and a parallel touring program for spouses and children.|
|A special gala awards dinner in The Davidson Center, Old City Jerusalem, where the Prime Minister of Israel has been invited to present to the 2005 worldwide recipients.|
The Mission sponsors are Forbes/Gottlieb Medical Technology Investor, Greenberg Traurig LLP, Harvard MIT Biomedical Engineering Center, and Rodman and Renshaw. The Chairmen for the USA are Dr. James Rothman - Professor, Columbia University College of Physicians and Surgeons, and Chief Science Advisor, GE Healthcare; Jonathan Silverstein – General Partner, OrbiMed Advisors, LLC; and Dr. Harlan F. Weisman – Company Group Chairman, Research & Development, Pharmaceuticals, Johnson & Johnson.
Participants have the option of choosing their level of participation – Silver, Gold or Platinum, and the Mission will also have two tracks giving participants the opportunity to choose the focus of their participation
|Track One - Global Innovation Summit: A Convergence of Life Sciences and Emerging/Disruptive Technologies, A Unique Thought Leadership Experience.|
|Track Two - Investment and Partnering: Bringing Together Emerging Growth Life Science Companies, Venture Capitalists, Institutional Investors and Major Pharmaceutical Executives|